SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.

Eyre, TA; Osborne, WL; Gallop-Evans, E; Ardeshna, KM; Kassam, S; Sadullah, S; Sidra, G; Culligan, D; Arumainathan, A; Shankara, P; et al. Eyre, TA; Osborne, WL; Gallop-Evans, E; Ardeshna, KM; Kassam, S; Sadullah, S; Sidra, G; Culligan, D; Arumainathan, A; Shankara, P; Bowles, KM; Eyre, DW; Peng, YY; Pettengell, R; Bloor, A; Vandenberghe, E; Collins, GP (2018) Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma. Br J Haematol, 181 (4). pp. 555-559. ISSN 1365-2141 https://doi.org/10.1111/bjh.14665
SGUL Authors: Pettengell, Ruth

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (910kB) | Preview
Item Type: Article
Additional Information: This is the peer reviewed version of the following article: Eyre, T. A., Osborne, W. L., Gallop‐Evans, E. , Ardeshna, K. M., Kassam, S. , Sadullah, S. , Sidra, G. , Culligan, D. , Arumainathan, A. , Shankara, P. , Bowles, K. M., Eyre, D. W., Peng, Y. Y., Pettengell, R. , Bloor, A. , Vandenberghe, E. and Collins, G. P. (2018), Results of a multicentre UK‐wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma. Br J Haematol, 181: 555-559, which has been published in final form at https://doi.org/10.1111/bjh.14665. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Keywords: PI3K, follicular lymphoma, idelalisib, Adult, Aged, Aged, 80 and over, Disease-Free Survival, Female, Follow-Up Studies, Humans, Lymphoma, Follicular, Male, Middle Aged, Purines, Quinazolinones, Recurrence, Survival Rate, United Kingdom, Humans, Lymphoma, Follicular, Recurrence, Purines, Disease-Free Survival, Survival Rate, Follow-Up Studies, Adult, Aged, Aged, 80 and over, Middle Aged, Female, Male, Quinazolinones, United Kingdom, follicular lymphoma, idelalisib, PI3K, 1102 Cardiovascular Medicine And Haematology, Immunology
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: Br J Haematol
ISSN: 1365-2141
Language: eng
Dates:
DateEvent
15 May 2018Published
24 March 2017Published Online
Publisher License: Publisher's own licence
PubMed ID: 28342183
Web of Science ID: WOS:000433566800020
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110247
Publisher's version: https://doi.org/10.1111/bjh.14665

Actions (login required)

Edit Item Edit Item